{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:15:04Z","timestamp":1791288904188,"version":"4.3.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Research Committee of the University of Thessaly, Greece","award":["5287"],"award-info":[{"award-number":["5287"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-024-02301-8","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T02:36:29Z","timestamp":1734489389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lack of Association between BDNF rs6265 and Multiple Sclerosis: A Case\u2013Control Study"],"prefix":"10.1007","volume":"75","author":[{"given":"Ioannis","family":"Liampas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniil","family":"Tsirelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metaxia","family":"Dastamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula-Ioanna","family":"Pariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papasavva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha-Spyridoula","family":"Katsarou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annia","family":"Tsolakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristidis","family":"Tsatsakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Drakoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimios","family":"Dardiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Siokas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"2301_CR1","doi-asserted-by":"publisher","unstructured":"Aguayo-Arelis A, Rabago-Barajas BV, Salda\u00f1a-Cruz AM, Mac\u00edas-Islas M (2023) Association of the BDNF rs6265 Polymorphism with Cognitive Impairment in Multiple Sclerosis: A Case-Control Study in Mexican Patients. Genes (Basel) 14(12). https:\/\/doi.org\/10.3390\/genes14122130","DOI":"10.3390\/genes14122130"},{"key":"2301_CR2","doi-asserted-by":"publisher","first-page":"105445","DOI":"10.1016\/j.msard.2024.105445","volume":"83","author":"A Armon-Omer","year":"2024","unstructured":"Armon-Omer A, Mansor T, Edelstein M, Bukovetzky E, Groisman L, Rorman E et al (2024) Association between multiple sclerosis and urinary levels of toxic metals and organophosphates: A cross-sectional study in Israel. Mult Scler Relat Disord 83:105445. https:\/\/doi.org\/10.1016\/j.msard.2024.105445","journal-title":"Mult Scler Relat Disord"},{"issue":"12","key":"2301_CR3","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.tig.2017.09.004","volume":"33","author":"SE Baranzini","year":"2017","unstructured":"Baranzini SE, Oksenberg JR (2017) The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years. Trends Genet 33(12):960\u2013970. https:\/\/doi.org\/10.1016\/j.tig.2017.09.004","journal-title":"Trends Genet"},{"issue":"6","key":"2301_CR4","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","volume":"11","author":"S Bathina","year":"2015","unstructured":"Bathina S, Das UN (2015) Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci 11(6):1164\u20131178. https:\/\/doi.org\/10.5114\/aoms.2015.56342","journal-title":"Arch Med Sci"},{"issue":"3","key":"2301_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/08977190410001723308","volume":"22","author":"DK Binder","year":"2004","unstructured":"Binder DK, Scharfman HE (2004) Brain-derived neurotrophic factor. Growth Factors 22(3):123\u2013131. https:\/\/doi.org\/10.1080\/08977190410001723308","journal-title":"Growth Factors"},{"issue":"3","key":"2301_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.neulet.2005.11.032","volume":"396","author":"Y Blanco","year":"2006","unstructured":"Blanco Y, G\u00f3mez-Choco M, Arostegui JL, Casanova B, Mart\u00ednez-Rodr\u00edguez JE, Bosc\u00e1 I et al (2006) No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis. Neurosci Lett 396(3):217\u2013219. https:\/\/doi.org\/10.1016\/j.neulet.2005.11.032","journal-title":"Neurosci Lett"},{"issue":"1","key":"2301_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/ana.23749","volume":"73","author":"D Buck","year":"2013","unstructured":"Buck D, Albrecht E, Aslam M, Goris A, Hauenstein N, Jochim A et al (2013) Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis. Ann Neurol 73(1):86\u201394. https:\/\/doi.org\/10.1002\/ana.23749","journal-title":"Ann Neurol"},{"issue":"11","key":"2301_CR8","doi-asserted-by":"publisher","first-page":"e958","DOI":"10.1038\/tp.2016.214","volume":"6","author":"A Cattaneo","year":"2016","unstructured":"Cattaneo A, Cattane N, Begni V, Pariante CM, Riva MA (2016) The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders. Transl Psychiatry 6(11):e958. https:\/\/doi.org\/10.1038\/tp.2016.214","journal-title":"Transl Psychiatry"},{"key":"2301_CR9","doi-asserted-by":"publisher","unstructured":"Coyle PK (2021) What can we learn from sex differences in MS? J Pers Med 11(10). https:\/\/doi.org\/10.3390\/jpm11101006","DOI":"10.3390\/jpm11101006"},{"key":"2301_CR10","doi-asserted-by":"publisher","unstructured":"Dolcetti E, Bruno A, Azzolini F, Gilio L, Moscatelli A, De Vito F et al (2022) The BDNF Val66Met polymorphism (rs6265) modulates inflammation and neurodegeneration in the early phases of multiple sclerosis. Genes (Basel) 13(2). https:\/\/doi.org\/10.3390\/genes13020332","DOI":"10.3390\/genes13020332"},{"key":"2301_CR11","doi-asserted-by":"publisher","unstructured":"Dolcetti E, Buttari F, Bruno A, Azzolini F, Gilio L, Borrelli A et al (2024) An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis. Int J Mol Sci 25(16). https:\/\/doi.org\/10.3390\/ijms25169108","DOI":"10.3390\/ijms25169108"},{"issue":"1","key":"2301_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1046\/j.1440-1711.1998.00718.x","volume":"76","author":"C Ewing","year":"1998","unstructured":"Ewing C, Bernard CC (1998) Insights into the aetiology and pathogenesis of multiple sclerosis. Immunol Cell Biol 76(1):47\u201354. https:\/\/doi.org\/10.1046\/j.1440-1711.1998.00718.x","journal-title":"Immunol Cell Biol"},{"issue":"4","key":"2301_CR13","doi-asserted-by":"publisher","first-page":"e61063","DOI":"10.1371\/journal.pone.0061063","volume":"8","author":"F Fera","year":"2013","unstructured":"Fera F, Passamonti L, Cerasa A, Gioia MC, Liguori M, Manna I et al (2013) The BDNF Val66Met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls. PLoS ONE 8(4):e61063. https:\/\/doi.org\/10.1371\/journal.pone.0061063","journal-title":"PLoS ONE"},{"key":"2301_CR14","doi-asserted-by":"publisher","unstructured":"Ferrari M, Vecchio D, D\u2019Alfonso S, Gemma A, Marino F, Comi C et al (2024) Polymorphisms in the Dopaminergic Receptor D3 Gene Correlate with Disease Progression Rate in Relapsing-Remitting Multiple Sclerosis Patients. Genes (Basel) 15(6). https:\/\/doi.org\/10.3390\/genes15060736","DOI":"10.3390\/genes15060736"},{"key":"2301_CR15","doi-asserted-by":"publisher","first-page":"102189","DOI":"10.1016\/j.msard.2020.102189","volume":"44","author":"HB Ferreira","year":"2020","unstructured":"Ferreira HB, Neves B, Guerra IM, Moreira A, Melo T, Paiva A et al (2020) An overview of lipidomic analysis in different human matrices of multiple sclerosis. Mult Scler Relat Disord 44:102189. https:\/\/doi.org\/10.1016\/j.msard.2020.102189","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"2301_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7861\/clinmed.2020-0292","volume":"20","author":"H Ford","year":"2020","unstructured":"Ford H (2020) Clinical presentation and diagnosis of multiple sclerosis. Clin Med (Lond) 20(4):380\u2013383. https:\/\/doi.org\/10.7861\/clinmed.2020-0292","journal-title":"Clin Med (Lond)"},{"key":"2301_CR17","doi-asserted-by":"publisher","first-page":"790360","DOI":"10.3389\/fneur.2022.790360","volume":"13","author":"A Giordano","year":"2022","unstructured":"Giordano A, Clarelli F, Cannizzaro M, Mascia E, Santoro S, Sorosina M et al (2022) BDNF Val66Met polymorphism is associated with motor recovery after rehabilitation in progressive multiple sclerosis patients. Front Neurol 13:790360. https:\/\/doi.org\/10.3389\/fneur.2022.790360","journal-title":"Front Neurol"},{"key":"2301_CR18","doi-asserted-by":"publisher","unstructured":"Guerini FR, Agliardi C, Bolognesi E, Zanzottera M, Caputo D, Pasanisi MB et al (2022) Two Single Nucleotide Polymorphisms in the Purinergic Receptor P2X7 Gene Are Associated with Disease Severity in Multiple Sclerosis. Int J Mol Sci 23(23): https:\/\/doi.org\/10.3390\/ijms232315381","DOI":"10.3390\/ijms232315381"},{"key":"2301_CR19","doi-asserted-by":"publisher","unstructured":"Haase S, Linker RA (2021) Inflammation in multiple sclerosis. Ther Adv Neurol Disord 14: 17562864211007687. https:\/\/doi.org\/10.1177\/17562864211007687. https:\/\/www.ensembl.org\/Homo_sapiens\/Variation\/Population?db=core;r=11:27657869-27658869;v=rs6265;vdb=variation;vf=706422091. Accessed 24\/08\/2024 2024","DOI":"10.1177\/17562864211007687"},{"key":"2301_CR20","doi-asserted-by":"publisher","unstructured":"International Multiple Sclerosis Genetics Consortium*\u2020, ANZgene, IIBDGC, WTCCC2 (2019) Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365(6460). https:\/\/doi.org\/10.1126\/science.aav7188","DOI":"10.1126\/science.aav7188"},{"issue":"1","key":"2301_CR21","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s11033-024-09369-w","volume":"51","author":"M Jamoussi","year":"2024","unstructured":"Jamoussi M, Alaya F, Jamoussi H, Baraket G, Achouri A, Mahmoud MB et al (2024) Vitamin D receptor gene BsmI (rs1544410) polymorphism: role in multiple sclerosis and genotype-phenotype correlations. Mol Biol Rep 51(1):478. https:\/\/doi.org\/10.1007\/s11033-024-09369-w","journal-title":"Mol Biol Rep"},{"key":"2301_CR22","doi-asserted-by":"publisher","first-page":"372423","DOI":"10.1155\/2010\/372423","volume":"2010","author":"Y Jiang","year":"2010","unstructured":"Jiang Y, Wei N, Zhu J, Lu T, Chen Z, Xu G et al (2010) Effects of brain-derived neurotrophic factor on local inflammation in experimental stroke of rat. Mediators Inflamm 2010:372423. https:\/\/doi.org\/10.1155\/2010\/372423","journal-title":"Mediators Inflamm"},{"key":"2301_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.msard.2019.01.033","volume":"29","author":"I Kiselev","year":"2019","unstructured":"Kiselev I, Bashinskaya V, Baulina N, Kozin M, Popova E, Boyko A et al (2019) Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability. Mult Scler Relat Disord 29:130\u2013136. https:\/\/doi.org\/10.1016\/j.msard.2019.01.033","journal-title":"Mult Scler Relat Disord"},{"key":"2301_CR24","doi-asserted-by":"publisher","unstructured":"Knyszy\u0144ska A, Skonieczna-\u017bydecka K, Koziarska D, Stachowska L, Kotwas A, Kulaszy\u0144ska M et al (2022) Searching for the Relationship between the Concentration of Heavy Metals in the Blood and the Clinical Course of Multiple Sclerosis: A Cross-Sectional Study in Poland. Int J Environ Res Public Health 19(11). https:\/\/doi.org\/10.3390\/ijerph19116548","DOI":"10.3390\/ijerph19116548"},{"issue":"1","key":"2301_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neurol.2015.10.006","volume":"172","author":"E Leray","year":"2016","unstructured":"Leray E, Moreau T, Fromont A, Edan G (2016) Epidemiology of multiple sclerosis. Rev Neurol (Paris) 172(1):3\u201313. https:\/\/doi.org\/10.1016\/j.neurol.2015.10.006","journal-title":"Rev Neurol (Paris)"},{"key":"2301_CR26","doi-asserted-by":"publisher","unstructured":"Liampas I, Siokas V, Aloizou AM, Bakirtzis C, Tsouris Z, Nousia A et al (2021) MOBP rs616147 polymorphism and risk of amyotrophic lateral sclerosis in a greek population: A case-control study. Medicina (Kaunas) 57(12). https:\/\/doi.org\/10.3390\/medicina57121337","DOI":"10.3390\/medicina57121337"},{"issue":"2","key":"2301_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1601-183X.2006.00245.x","volume":"6","author":"M Liguori","year":"2007","unstructured":"Liguori M, Fera F, Gioia MC, Valentino P, Manna I, Condino F et al (2007) Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis. Genes Brain Behav 6(2):177\u2013183. https:\/\/doi.org\/10.1111\/j.1601-183X.2006.00245.x","journal-title":"Genes Brain Behav"},{"issue":"1\u20132","key":"2301_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jneuroim.2005.06.008","volume":"167","author":"S Lindquist","year":"2005","unstructured":"Lindquist S, Schott BH, Ban M, Compston DA, Sawcer S, Sailer M (2005) The BDNF-Val66Met polymorphism: implications for susceptibility to multiple sclerosis and severity of disease. J Neuroimmunol 167(1\u20132):183\u2013185. https:\/\/doi.org\/10.1016\/j.jneuroim.2005.06.008","journal-title":"J Neuroimmunol"},{"issue":"3","key":"2301_CR29","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/wco.0000000000000695","volume":"32","author":"M Magyari","year":"2019","unstructured":"Magyari M, Sorensen PS (2019) The changing course of multiple sclerosis: rising incidence, change in geographic distribution, disease course, and prognosis. Curr Opin Neurol 32(3):320\u2013326. https:\/\/doi.org\/10.1097\/wco.0000000000000695","journal-title":"Curr Opin Neurol"},{"key":"2301_CR30","doi-asserted-by":"publisher","first-page":"1385042","DOI":"10.3389\/fneur.2024.1385042","volume":"15","author":"M Maiworm","year":"2024","unstructured":"Maiworm M (2024) The relevance of BDNF for neuroprotection and neuroplasticity in multiple sclerosis. Front Neurol 15:1385042. https:\/\/doi.org\/10.3389\/fneur.2024.1385042","journal-title":"Front Neurol"},{"issue":"1\u20132","key":"2301_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jns.2008.02.011","volume":"270","author":"TK Makar","year":"2008","unstructured":"Makar TK, Trisler D, Sura KT, Sultana S, Patel N, Bever CT (2008) Brain derived neurotrophic factor treatment reduces inflammation and apoptosis in experimental allergic encephalomyelitis. J Neurol Sci 270(1\u20132):70\u201376. https:\/\/doi.org\/10.1016\/j.jns.2008.02.011","journal-title":"J Neurol Sci"},{"issue":"12","key":"2301_CR32","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s1474-4422(04)00933-0","volume":"3","author":"RA Marrie","year":"2004","unstructured":"Marrie RA (2004) Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 3(12):709\u2013718. https:\/\/doi.org\/10.1016\/s1474-4422(04)00933-0","journal-title":"Lancet Neurol"},{"issue":"2","key":"2301_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/gbb.12190","volume":"14","author":"T Matsushita","year":"2015","unstructured":"Matsushita T, Madireddy L, Sprenger T, Khankhanian P, Magon S, Naegelin Y et al (2015) Genetic associations with brain cortical thickness in multiple sclerosis. Genes Brain Behav 14(2):217\u2013227. https:\/\/doi.org\/10.1111\/gbb.12190","journal-title":"Genes Brain Behav"},{"issue":"1\u20132","key":"2301_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jneuroim.2012.01.011","volume":"244","author":"IL Mero","year":"2012","unstructured":"Mero IL, Smestad C, Lie BA, Lorentzen \u00c5R, Sandvik L, Landr\u00f8 NI et al (2012) Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course. J Neuroimmunol 244(1\u20132):107\u2013110. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.01.011","journal-title":"J Neuroimmunol"},{"key":"2301_CR35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fncel.2019.00363","volume":"13","author":"M Miranda","year":"2019","unstructured":"Miranda M, Morici JF, Zanoni MB, Bekinschtein P (2019) Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain. Front Cell Neurosci 13:363. https:\/\/doi.org\/10.3389\/fncel.2019.00363","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"2301_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/19338244.2014.937381","volume":"71","author":"MD Napier","year":"2016","unstructured":"Napier MD, Poole C, Satten GA, Ashley-Koch A, Marrie RA, Williamson DM (2016) Heavy metals, organic solvents, and multiple sclerosis: An exploratory look at gene-environment interactions. Arch Environ Occup Health 71(1):26\u201334. https:\/\/doi.org\/10.1080\/19338244.2014.937381","journal-title":"Arch Environ Occup Health"},{"issue":"1","key":"2301_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4103\/1673-5374.343894","volume":"18","author":"VT Nguyen","year":"2023","unstructured":"Nguyen VT, Hill B, Sims N, Heck A, Negron M, Lusk C et al (2023) Brain-derived neurotrophic factor rs6265 (Val66Met) single nucleotide polymorphism as a master modifier of human pathophysiology. Neural Regen Res 18(1):102\u2013106. https:\/\/doi.org\/10.4103\/1673-5374.343894","journal-title":"Neural Regen Res"},{"key":"2301_CR38","doi-asserted-by":"publisher","unstructured":"Patsopoulos NA (2018) Genetics of multiple sclerosis: an overview and new directions. Cold Spring Harb Perspect Med 8(7). https:\/\/doi.org\/10.1101\/cshperspect.a028951","DOI":"10.1101\/cshperspect.a028951"},{"key":"2301_CR39","doi-asserted-by":"publisher","first-page":"645220","DOI":"10.3389\/fneur.2021.645220","volume":"12","author":"E Portaccio","year":"2021","unstructured":"Portaccio E, Bellinvia A, Prestipino E, Nacmias B, Bagnoli S, Razzolini L et al (2021) The brain-derived neurotrophic factor Val66Met polymorphism can protect against cognitive impairment in multiple sclerosis. Front Neurol 12:645220. https:\/\/doi.org\/10.3389\/fneur.2021.645220","journal-title":"Front Neurol"},{"issue":"1","key":"2301_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pathophys.2010.04.006","volume":"18","author":"DP Ramasamy","year":"2011","unstructured":"Ramasamy DP, Ramanathan M, Cox JL, Antulov R, Weinstock-Guttman B, Bergsland N et al (2011) Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: A voxel-based morphometry study. Pathophysiology 18(1):53\u201360. https:\/\/doi.org\/10.1016\/j.pathophys.2010.04.006","journal-title":"Pathophysiology"},{"issue":"1","key":"2301_CR41","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12874-024-02264-9","volume":"24","author":"AM Sakr","year":"2024","unstructured":"Sakr AM, Mansmann U, Havla J, \u00d6n BI, \u00d6n BI (2024) Framework for personalized prediction of treatment response in relapsing-remitting multiple sclerosis: a replication study in independent data. BMC Med Res Methodol 24(1):138. https:\/\/doi.org\/10.1186\/s12874-024-02264-9","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2301_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12017-018-8519-5","volume":"21","author":"V Siokas","year":"2019","unstructured":"Siokas V, Kardaras D, Aloizou AM, Asproudis I, Boboridis KG, Papageorgiou E et al (2019) BDNF rs6265 (Val66Met) polymorphism as a risk factor for blepharospasm. Neuromolecular Med 21(1):68\u201374. https:\/\/doi.org\/10.1007\/s12017-018-8519-5","journal-title":"Neuromolecular Med"},{"issue":"4","key":"2301_CR43","doi-asserted-by":"publisher","first-page":"106","DOI":"10.31083\/j.jin2204106","volume":"22","author":"V Siokas","year":"2023","unstructured":"Siokas V, Liampas I, Aloizou AM, Bakirtzis C, Tsouris Z, Nousia A et al (2023) Lack of Association between CD33 rs3865444 and Amyotrophic Lateral Sclerosis: A Case-Control Study. J Integr Neurosci 22(4):106. https:\/\/doi.org\/10.31083\/j.jin2204106","journal-title":"J Integr Neurosci"},{"key":"2301_CR44","doi-asserted-by":"publisher","unstructured":"Siokas V, Aloizou AM, Liampas I, Bakirtzis C, Nasios G, Paterakis K et al (2022) Lack of an association between SCFD1 rs10139154 polymorphism and amyotrophic lateral sclerosis. Mol Med Rep 25(4). https:\/\/doi.org\/10.3892\/mmr.2022.12662","DOI":"10.3892\/mmr.2022.12662"},{"issue":"2","key":"2301_CR45","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ng1706","volume":"38","author":"AD Skol","year":"2006","unstructured":"Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38(2):209\u2013213. https:\/\/doi.org\/10.1038\/ng1706","journal-title":"Nat Genet"},{"issue":"3","key":"2301_CR46","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12031-018-1046-x","volume":"64","author":"M Sokratous","year":"2018","unstructured":"Sokratous M, Dardiotis E, Bellou E, Tsouris Z, Michalopoulou A, Dardioti M et al (2018) CpG island methylation patterns in relapsing-remitting multiple sclerosis. J Mol Neurosci 64(3):478\u2013484. https:\/\/doi.org\/10.1007\/s12031-018-1046-x","journal-title":"J Mol Neurosci"},{"issue":"15","key":"2301_CR47","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","volume":"22","author":"X Sol\u00e9","year":"2006","unstructured":"Sol\u00e9 X, Guin\u00f3 E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22(15):1928\u20131929. https:\/\/doi.org\/10.1093\/bioinformatics\/btl268","journal-title":"Bioinformatics"},{"key":"2301_CR48","doi-asserted-by":"publisher","unstructured":"Stro\u0144ska-Pluta A, Suchanecka A, Chmielowiec K, Chmielowiec J, Boro\u0144 A, Masiak J et al (2024) The Relationship between the Brain-Derived Neurotrophic Factor Gene Polymorphism (Val66Met) and Substance Use Disorder and Relapse. Int J Mol Sci 25(2): https:\/\/doi.org\/10.3390\/ijms25020788","DOI":"10.3390\/ijms25020788"},{"issue":"2","key":"2301_CR49","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/s1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173. https:\/\/doi.org\/10.1016\/s1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"issue":"5","key":"2301_CR50","doi-asserted-by":"publisher","first-page":"160","DOI":"10.17116\/jnevro2023123051160","volume":"123","author":"MA Titova","year":"2023","unstructured":"Titova MA, Alifirova VM, Kamenskikh EM, Musina NF, Nikolaeva TN, Paderina DZ et al (2023) BDNF gene RS6265 polymorphism in patients with multiple sclerosis of Tomsk region. Zh Nevrol Psikhiatr Im S S Korsakova 123(5):160\u2013164. https:\/\/doi.org\/10.17116\/jnevro2023123051160","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"2301_CR51","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fmolb.2019.00120","volume":"6","author":"D Tsoukalas","year":"2019","unstructured":"Tsoukalas D, Fragoulakis V, Sarandi E, Docea AO, Papakonstaninou E, Tsilimidos G et al (2019) Targeted metabolomic analysis of serum fatty acids for the prediction of autoimmune diseases. Front Mol Biosci 6:120. https:\/\/doi.org\/10.3389\/fmolb.2019.00120","journal-title":"Front Mol Biosci"},{"key":"2301_CR52","doi-asserted-by":"publisher","unstructured":"Valiukevicius P, Kaikaryte K, Gedvilaite-Vaicechauskiene G, Balnyte R, Liutkeviciene R (2024) CXCL12 Gene Polymorphisms and Serum Levels: Associations with Multiple Sclerosis Prevalence and Clinical Parameters in Lithuania. Int J Mol Sci 25(17). https:\/\/doi.org\/10.3390\/ijms25179554","DOI":"10.3390\/ijms25179554"},{"key":"2301_CR53","doi-asserted-by":"publisher","first-page":"1285103","DOI":"10.3389\/fpubh.2023.1285103","volume":"11","author":"BK Vitturi","year":"2023","unstructured":"Vitturi BK, Montecucco A, Rahmani A, Dini G, Durando P (2023) Occupational risk factors for multiple sclerosis: a systematic review with meta-analysis. Front Public Health 11:1285103. https:\/\/doi.org\/10.3389\/fpubh.2023.1285103","journal-title":"Front Public Health"},{"issue":"4","key":"2301_CR54","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"2301_CR55","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/s1474-4422(18)30443-5","volume":"18","author":"MT Wallin","year":"2019","unstructured":"Wallin MT, Culpepper WJ, Nichols E, Bhutta ZA, Gebrehiwot TT, Hay SI, Khalil IA, Krohn KJ, Liang X, Naghavi M, Mokdad AH (2019) Global, regional, and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(3):269\u2013285. https:\/\/doi.org\/10.1016\/s1474-4422(18)30443-5","journal-title":"Lancet Neurol"},{"issue":"14","key":"2301_CR56","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA et al (2020) Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS. Mult Scler 26(14):1816\u20131821. https:\/\/doi.org\/10.1177\/1352458520970841","journal-title":"Mult Scler"},{"issue":"9","key":"2301_CR57","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/acn3.50862","volume":"6","author":"E Waubant","year":"2019","unstructured":"Waubant E, Lucas R, Mowry E, Graves J, Olsson T, Alfredsson L et al (2019) Environmental and genetic risk factors for MS: an integrated review. Ann Clin Transl Neurol 6(9):1905\u20131922. https:\/\/doi.org\/10.1002\/acn3.50862","journal-title":"Ann Clin Transl Neurol"},{"key":"2301_CR58","doi-asserted-by":"publisher","first-page":"1448215","DOI":"10.3389\/fnmol.2024.1448215","volume":"17","author":"JM Wilkins","year":"2024","unstructured":"Wilkins JM, Mangalaparthi KK, Netzel BC, Sherman WA, Guo Y, Kalinowska-Lyszczarz A et al (2024) Proteomics analysis of periplaque and chronic inactive multiple sclerosis lesions. Front Mol Neurosci 17:1448215. https:\/\/doi.org\/10.3389\/fnmol.2024.1448215","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"2301_CR59","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12974-017-0930-6","volume":"14","author":"D Xu","year":"2017","unstructured":"Xu D, Lian D, Wu J, Liu Y, Zhu M, Sun J et al (2017) Brain-derived neurotrophic factor reduces inflammation and hippocampal apoptosis in experimental Streptococcus pneumoniae meningitis. J Neuroinflammation 14(1):156. https:\/\/doi.org\/10.1186\/s12974-017-0930-6","journal-title":"J Neuroinflammation"},{"key":"2301_CR60","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3389\/fimmu.2020.01357","volume":"11","author":"S Zhao","year":"2020","unstructured":"Zhao S, Zhang Z, Xu D, Wang Y, Li L (2020) Selective loss of brain-derived neurotrophic factor exacerbates brain injury by enhancing neuroinflammation in experimental streptococcus pneumoniae meningitis. Front Immunol 11:1357. https:\/\/doi.org\/10.3389\/fimmu.2020.01357","journal-title":"Front Immunol"},{"key":"2301_CR61","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1471-2288-11-171","volume":"11","author":"E Zintzaras","year":"2011","unstructured":"Zintzaras E, Santos M (2011) Estimating the mode of inheritance in genetic association studies of qualitative traits based on the degree of dominance index. BMC Med Res Methodol 11:171. https:\/\/doi.org\/10.1186\/1471-2288-11-171","journal-title":"BMC Med Res Methodol"},{"issue":"22","key":"2301_CR62","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/hmg\/ddm189","volume":"16","author":"R Zivadinov","year":"2007","unstructured":"Zivadinov R, Weinstock-Guttman B, Benedict R, Tama\u00f1o-Blanco M, Hussein S, Abdelrahman N et al (2007) Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. Hum Mol Genet 16(22):2659\u20132668. https:\/\/doi.org\/10.1093\/hmg\/ddm189","journal-title":"Hum Mol Genet"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-024-02301-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-024-02301-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-024-02301-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T14:46:40Z","timestamp":1743691600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-024-02301-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["2301"],"URL":"https:\/\/doi.org\/10.1007\/s12031-024-02301-8","relation":{},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent. The study protocol received the approval of the local ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1"}}